We are proud to introduce the addition of two remarkable individuals to our Board of Directors. Each new member brings a wealth of diverse experience and knowledge to our team which will further strengthen Amferia’s position in addressing antibiotic resistance and infection management.
Anders Husmark has over 20 years of leadership experience within woundcare and surgical care, and was previously the R&D Director, Surgical Division, Mölnlycke Health Care followed by leading Business Development for RLS Global. Anders brings decades of expereince and practical knowledge on clinical implementation of new technologies that will serve as the foundation for next steps for Amferia, when entering the human health market.
Henrik Jansson is presently an CEO and Investment Director at Almi Invest Väst Svergie focusing on medtech, healthtech and greentech. Henrik has over 20 years of experience in the building and running companies and has a broad knowledge on scaling up operations and long-term strateigc development.
